For five decades, scientists have known about a notorious cancer-causing enzyme called SRC. But they always assumed it only ...

A US pelvic health expert has urged people to ditch this unnecessary - and possibly detrimental - act.

Copies of Astellas Pharma Inc.‘s Myrbetriq ER proposed by Ascent Pharmaceuticals Inc. infringe four patents for the overactive-bladder drug, a federal judge ruled, delaying their launch until 2030.